Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
0,0074 USD | -3,90% | -12,94% | -12,94% |
23/02 | L'Istituto di Ricerca Biomedica Corp. presenta M2BioKids | CI |
30/01 | Real American Capital Corp. (OTCPK:RLAB) ha acquisito M2MMA da Institute of Biomedical Research Corp. (OTCPK:MRES). | CI |
Vendite per attività
USD in Milioni | 2014 | Peso | 2015 | Peso | Delta |
---|---|---|---|---|---|
Alternative Plant-based Cannabinoids and Mental hHalth Therapeutic Research
100,0
%
| 1 | 100,0 % | 1 | 100,0 % | +24,68% |
Vendite per regione
USD in Milioni | 2014 | Peso | 2015 | Peso | Delta |
---|---|---|---|---|---|
Canada
100,0
%
| 1 | 100,0 % | 1 | 100,0 % | +24,68% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Peter Robinson
CEO | Chief Executive Officer | - | 11/07/22 |
Willem Jonker
DFI | Director of Finance/CFO | 66 | - |
Chief Tech/Sci/R&D Officer | - | - | |
Marko Maljkovic
SAM | Sales & Marketing | - | - |
Zeljko Jacimovic
PRN | Corporate Officer/Principal | - | - |
Momir Mikov
PRN | Corporate Officer/Principal | - | - |
Veselin Delevic
PRN | Corporate Officer/Principal | - | - |
Richard Morisset
PRN | Corporate Officer/Principal | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Chief Tech/Sci/R&D Officer | - | - | |
Peter Robinson
CEO | Chief Executive Officer | - | 11/07/22 |
Willem Jonker
DFI | Director of Finance/CFO | 66 | - |
Coordinate società
Institute of BioMedical Research Corp.
Jele Andrijasevic 2 Niksic
81004, Niksic
+
http://www.mrescorp.comSettore
- Borsa valori
- Azioni
- Azione MRES
- Società Institute of Biomedical Research Corp.